Skip to content

Drug binding poses relate structure with efficacy in the μ opioid receptor

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1840-1851
Number of pages12
JournalJournal of Molecular Biology
Issue number12
Early online date11 May 2017
DateAccepted/In press - 8 May 2017
DateE-pub ahead of print - 11 May 2017
DatePublished (current) - 16 Jun 2017


The μ-opioid receptor (MOPr) is a clinically important G protein-coupled receptor (GPCR) which couples to Gi/o proteins and arrestins. At present the receptor conformational changes that occur following agonist binding and activation are poorly understood. This study has employed molecular dynamics simulations to investigate the binding mode and receptor conformational changes induced by structurally similar opioid ligands of widely differing intrinsic agonist efficacy, norbuprenorphine, buprenorphine and diprenorphine. Bioluminescence resonance energy transfer (BRET) assays for Gi activation and arrestin-3 recruitment in HEK 293 cells confirmed that norbuprenorphine is a high efficacy agonist, buprenorphine a low efficacy agonist, and diprenorphine an antagonist at the MOPr. Molecular dynamics simulations revealed that these ligands adopt distinct binding poses and engage different subsets of residues, despite sharing a common morphinan scaffold. Notably, norbuprenorphine interacted with sodium ion - coordinating residues W293(6.48) and N150(3.35), whilst buprenorphine and diprenorphine did not. Principal component analysis of the movements of the receptor transmembrane domains showed that the buprenorphine-bound receptor occupied a distinct set of conformations to the norbuprenorphine-bound receptor. Addition of an allosteric sodium ion caused the receptor and ligand to adopt an inactive conformation. The differences in ligand-residue interactions and receptor conformations observed here may underlie the differing efficacies for cellular signalling outputs for these ligands.

    Structured keywords

  • BcompB

    Research areas

  • G protein-coupled receptor, μ-opioid receptor, molecular dynamics, buprenorphine

Download statistics

No data available



  • Full-text PDF (final published version)

    Rights statement: This is the final published version of the article (version of record). It first appeared online via ELSEVIER at . Please refer to any applicable terms of use of the publisher.

    Final published version, 1.72 MB, PDF document

    Licence: CC BY


View research connections

Related faculties, schools or groups